Effect of bowel cleansing for colonoscopy on fecal calprotectin levels in pediatric patients

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 6, 2012, Pages 751-753

  Kolho, Kaija Leena ^a,c   Alfthan, Henrik ^b   Hämäläinen, Esa ^b  

^a UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Children; Fecal biomarkers; Inflammatory bowel disease; Intestine

Indexed keywords

CALGRANULIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COLON LAVAGE; COLONOSCOPY; CROHN DISEASE; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INTESTINE PREPARATION; MALE; PRIORITY JOURNAL; SCHOOL CHILD; ULCERATIVE COLITIS;

ADOLESCENT; BIOLOGICAL MARKERS; CATHARTICS; CHILD; CHRONIC DISEASE; COLON; COLONOSCOPY; FECES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; PROSPECTIVE STUDIES;

EID: 84870928866     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31825f4c77     Document Type: Article

References (11)

1. Roseth AG, Aadland E, Jahnsen J, et al. Assessment of the disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 1997;58:176-80.
2. Bunn SK, Bisset WM, Main MJ, et al. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001;33:14-22.
3. Kolho KL, Raivio T, Lindahl H, et al. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Scand J Gastroenterol 2006;41:720-5.
4. Langhorst J, Elsenbruch S, Koelzer J, et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 2008;103:162-9.
5. Sipponen T, Savilahti E, Kolho KL, et al. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 2008;14:40-6.
6. Jensen MD, Kjeldsen J, Nathan T. Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon. Scand J Gastroenterol 2011;46:694-700.
7. Shaoul R, Sladek M, Turner D, et al. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease. Inflamm Bowel Dis 2012;18:1493-7.
8. Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-11-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999;34:50-4.
9. Moum B, Jahnsen J, Bernklev T. Fecal calprotectin variability in Crohn's disease. Inflamm Bowel Dis 2010;16:1091-2.
10. Henderson P, Casey A, Lawrence SJ, et al. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease. Am J Gastroenterol 2012;107:941-9.
11. Hämäläinen A, Sipponen T, Kolho KL. Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin values. World J Gastroenterol 2011;17:5166-71.